Review ArticleAdvances in next-generation lipid-polymer hybrid nanocarriers with emphasis on polymer-modified functional liposomes and cell-based-biomimetic nanocarriers for active ingredients and fractions from Chinese medicine delivery
Graphical Abstract
As the next generation of lipid-polymer hybrid nanocarriers (LPNs), functional polymer modified liposomes and cell-based-biomimetic LPNs offer powerful carriers and allow efficient drug delivery. They are beneficial for the enhancement of oral absorption and bioavailability, modulating release, improving biological membrane permeability, targeting delivery, overcoming multidrug resistance, and others.
Section snippets
Polymer-modified liposomes
Polymer-modified liposomes refer to the polymer-caged or polymer-incorporated liposomes hybrid nanocarriers that are composed of polymers anchored or grafted at the surfaces of the liposomes. The use of polymers is also beneficial in generating liposomes with improved properties, such as shape, particle size, zeta potential, surface properties, and membrane flexibility; these properties play an important role in their behavior in vitro and in vivo.
Cell membrane-biofunctionalized nanoparticles
After synthetic nanocarriers enter the bloodstream, they will suffer clearance by the reticuloendothelial system (RES)/mononuclear phagocyte system (MPS) and ‘protein corona’ by the adsorption of proteins and other biomolecules. To reduce these effects, coating with PEG polymer or controlling the size and architecture of the nanoparticles has been extensively investigated. However, due to the toxicological effect of PEG and ‘accelerated blood clearance (ABC)’ phenomenon, alternative nanocoating
Acknowledgement
This work was funded by the National Natural Science Foundation of China (No. 81773913, No. 81303232).
References (122)
- et al.
The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China
J Ethnopharmacol
(2013) - et al.
Approaches to establish Q-markers for the quality standards of traditional Chinese medicines
Acta Pharm Sin B
(2017) - et al.
Mesenchymal stem cells-curcumin loaded chitosan nanoparticles hybrid vectors for tumor-tropic therapy
Int J Biol Macromol
(2019) - et al.
Transferrin-targeted, resveratrol-loaded liposomes for the treatment of glioblastoma
J Control Release
(2018) - et al.
Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes
Int J Pharm
(2017) - et al.
Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer
Biomed Pharmacother
(2019) - et al.
Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG 2000 -transferrin in treatment of brain glioma
Eur J Pharm Sci
(2017) - et al.
Camptothecin encapsulated into functionalized MCM-41: in vitro release study, cytotoxicity and kinetics
Korean J Couns Psychother
(2019) - et al.
Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes
Biomaterials
(2013) - et al.
A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: characterization and protective effect against oxidative damage
Int J Pharm
(2018)
Optimized liposomes with transactivator of transcription peptide and anti-apoptotic drugs to target hippocampal neurons and prevent tau-hyperphosphorylated neurodegeneration
Acta Biomater
Antioxidant activity of quercetin in Eudragit-coated liposomes for intestinal delivery
Int J Pharm
Physico-chemical characterization of succinyl chitosan-stabilized liposomes for the oral co-delivery of quercetin and resveratrol
Carbohydr Polym
Topical delivery of anti-TNFα siRNA and capsaicin via novel lipid-polymer hybrid nanoparticles efficiently inhibits skin inflammation in vivo
J Control Release
Gallic acid liposomes decorated with lactoferrin: characterization, in vitro digestion and antibacterial activity
Food Chem
Quercetin deformable liposome: preparation and efficacy against ultraviolet B induced skin damages in vitro and in vivo
J Photochem Photobiol B
Cell penetrating peptide conjugated liposomes as transdermal delivery system of Polygonum aviculare L. extract
Int J Pharm
Functional lipid polymeric nanoparticles for oral drug delivery: rapid mucus penetration and improved cell entry and cellular transport
Nanomedicine
Nanocarriers for the delivery of active ingredients and fractions extracted from natural products used in traditional Chinese medicine (TCM)
Adv Colloid Interface Sci
Lipids and polymers in pharmaceutical technology: lifelong companions
Int J Pharm
Lipid-polymer hybrid nanocarriers for delivering cancer therapeutics
J Control Release
Chitosan and hyaluronan coated liposomes for pulmonary administration of curcumin
Int J Pharm
Multiple polysaccharide-drug complex-loaded liposomes: a unique strategy in drug loading and cancer targeting
Carbohydr Polym
Surface modification of solid lipid nanoparticles for oral delivery of curcumin: improvement of bioavailability through enhanced cellular uptake, and lymphatic uptake
Eur J Pharm Biopharm
Hybrid liposomes composed of amphiphilic chitosan and phospholipid: preparation, stability and bioavailability as a carrier for curcumin
Carbohydr Polym
Lipid-associated oral delivery: mechanisms and analysis of oral absorption enhancement
J Control Release
Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review
Eur J Pharm Biopharm
The suitability of liposomes for the delivery of hydrophobic drugs - a case study with curcumin
Eur J Pharm Biopharm
Preparation, characterization, pharmacokinetics, and bioactivity of honokiol-in-hydroxypropyl-β-cyclodextrin-in-liposome
J Pharm Sci
To what extent do polymeric stabilizers affect nanoparticles characteristics?
Adv Colloid Interface Sci
Improved stability and skin permeability of sodium hyaluronate-chitosan multilayered liposomes by layer-by-layer electrostatic deposition for quercetin delivery
Colloids Surf B Biointerfaces
Inducing sustained release and improving oral bioavailability of curcumin via chitosan derivatives-coated liposomes
Int J Biol Macromol
Variations in gastrointestinal lipases, pH and bile acid levels with food intake, age and diseases: possible impact on oral lipid-based drug delivery systems
Adv Drug Deliv Rev
'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug
J Control Release
Submicron complex lipid carriers for curcumin delivery to intestinal epithelial cells: effect of different emulsifiers on bioaccessibility and cell uptake
Int J Pharm
In-vitro digestion of curcumin loaded chitosan-coated liposomes
Colloids Surf B Biointerfaces
Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers
Adv Drug Deliv Rev
The role of mucus on drug transport and its potential to affect therapeutic outcomes
Adv Drug Deliv Rev
Self-emulsifying drug delivery system: mucus permeation and innovative quantification technologies
Adv Drug Deliv Rev
Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review
Prog Polym Sci
Mucoadhesive vs. mucopenetrating particulate drug delivery
Eur J Pharm Biopharm
Engineering nanomaterials to overcome the mucosal barrier by modulating surface properties
Adv Drug Deliv Rev
Adapting liposomes for oral drug delivery
Acta Pharm Sin B
Mucoadhesive liposomes as new formulation for vaginal delivery of curcumin
Eur J Pharm Biopharm
Resveratrol-loaded liposomes for topical treatment of the vaginal inflammation and infections
Eur J Pharm Sci
Beyond PEGylation: alternative surface-modification of nanoparticles with mucus-inert biomaterials
Adv Drug Deliv Rev
Mucus adhesion- and penetration-enhanced liposomes for paclitaxel oral delivery
Int J Pharm
Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals
J Nutr Biochem
Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery
Biomaterials
Uptake and transport of B12-conjugated nanoparticles in airway epithelium
J Control Release
Cited by (0)
Funding statement:
This work was funded by the National Natural Science Foundation of China (No. 81773913, No. 81303232).
Conflicts of interest:
The authors declare that no competing interests are present.
- 1
These authors contributed equally to this work.